Evaluation of arterial stiffness in patients with schizophrenia

dc.contributor.authorBaykara, Sema
dc.contributor.authorBozdag, Pinar Gundogan
dc.contributor.authorBaykara, Murat
dc.contributor.authorNamli, Mustafa Nuray
dc.date.accessioned2026-08-12T17:18:34Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractThe aim of this study was to evaluate arterial stiffness in schizophrenia patients. 28 male patients were included. The intima-media thickness (IMT) of the vessels were taken using high-resolution ultrasonography system. The mean carotid IMT and the mean femoral IMT values of the study group were found to be statistically significantly higher than the values of the control group. As the duration of the disease increased, there was an increase in the carotid IMT, carotid elastic modulus and femoral IMT, whereas there was a decrease in carotid and femoral diastolic wall stress in patients. No statistically significant differences were observed between the groups' carotid and femoral compliance, distensibility and elastic modulus values. The mean systolic arterial blood pressure in the patient group was determined to be lower than that of the control group. The mean diastolic wall stress values in the carotid and femoral arteries were determined to be lower than those of the control group. There was no relationship between antipsychotic dose, blood pressure and arterial stiffness parameters. Schizophrenia patients are more prone to develop arterial stiffness by atherosclerosis either with the effect of the nature of the disease itself or antipsychotic treatment. But evaluation with more parameters (carotid and femoral compliance, distensibility and elastic modulus) did not indicate any difference from the control group in respect of arterial stiffness. Antipsychotic treatment may play a protective role in terms of arterial stiffness by causing a decrease in systolic arterial pressure and carotid and femoral diastolic wall stress. (C) 2020 Elsevier Ltd. All rights reserved.
dc.identifier.doi10.1016/j.jocn.2020.07.008
dc.identifier.endpage153
dc.identifier.issn0967-5868
dc.identifier.issn1532-2653
dc.identifier.orcid0000-0002-7303-5832
dc.identifier.orcid0000-0001-9778-4216
dc.identifier.orcid0000-0003-2588-9013
dc.identifier.pmid33070886
dc.identifier.scopus2-s2.0-85089094481
dc.identifier.scopusqualityQ1
dc.identifier.startpage149
dc.identifier.urihttps://doi.org/10.1016/j.jocn.2020.07.008
dc.identifier.urihttps://hdl.handle.net/11508/53089
dc.identifier.volume79
dc.identifier.wosWOS:000581927800030
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofJournal of Clinical Neuroscience
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectVascular stiffness
dc.subjectSchizophrenia
dc.subjectAntipsychotic agents
dc.titleEvaluation of arterial stiffness in patients with schizophrenia
dc.typeArticle

Dosyalar